Newron Pharmaceuticals Spa. (NP5.F) Q3 2024 Earnings

19SepConfirmed
Q1 2024
Q3 2024
-0.49
-0.16
0.18
0.51

Details

Expected EPS
N/A
Actual EPS
-0.4895190850319999
Surprise EPS
-0.49
Surprise Percent
+∞%

Description

Newron Pharmaceuticals Spa. (NP5.F) has reported earnings of -0.4895190850319999 per share for Q3 2024.

0 Comments

Share your thoughts